Page 14 - Clarus Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clarus therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clarus Therapeutics Today - Breaking & Trending Today

Summary Judgment Ruling in Patent Infringement Lawsuit

/PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the. ....

United States , Mahesh Patel , Prnewswire Lipocine Inc , United States District Court , Lipocine Inc , Clarus Therapeutics Inc , District Of Delaware Court , Clarus Therapeutics , Summary Judgment , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , மகேஷ் படேல் , ஒன்றுபட்டது மாநிலங்களில் மாவட்டம் நீதிமன்றம் , கிளாரஸ் சிகிச்சை இன்க் , கிளாரஸ் சிகிச்சை , சுருக்கம் தீர்ப்பு , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

Clarus Therapeutics Defeats Lipocine's Patent Infringement Lawsuit On Summary Judgment

Clarus Therapeutics Defeats Lipocine's Patent Infringement Lawsuit On Summary Judgment
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Williamc Bryson , David Schull , Robert Dudley , Us Court , Lipocine Inc , Us District Court , Clarus Therapeutics Inc , Federal Circuit Judge William , Senior Circuit Judge , Federal Circuit , Judge Bryson , Clarus Therapeutics , Blue Water , Clarus Therapeutic , Investor Relations Contact , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் டட்லி , எங்களுக்கு நீதிமன்றம் , எங்களுக்கு மாவட்டம் நீதிமன்றம் , கிளாரஸ் சிகிச்சை இன்க் , மூத்தவர் சுற்று நீதிபதி , கூட்டாட்சியின் சுற்று , நீதிபதி பிரைசன் ,

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2021

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2021
News provided by
Share this article
Share this article
SALT LAKE CITY, May 6, 2021 /PRNewswire/ Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the first quarter ended March 31, 2021 and provided a corporate update.
First Quarter Recent Corporate Highlights
Announced positive topline results from the Phase 2
LiFT ( Liver Fat intervention with oral Testosterone ) clinical study, investigating LPCN 1144 in biopsy-confirmed NASH male subjects
Both LPCN 1144 treatment arms met the primary endpoint, change in hepatic fat fraction via magnetic resonance imaging proton density fat fraction ( MRI-PDFF ), with statistical significance ....

Lipocine Inc , Clarus Therapeutics Inc , Liver Health , Metabolic Regulation , High Fat Diet Induced , Quarter Ended March , Clarus Therapeutics , Private Securities Litigation Reform Act , Consolidated Statements , Months Ended March , கிளாரஸ் சிகிச்சை இன்க் , கல்லீரல் ஆரோக்கியம் , வளர்சிதை மாற்ற ஒழுங்குமுறை , கிளாரஸ் சிகிச்சை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , தொகுக்கப்பட்டு அறிக்கைகள் ,

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Blue Water Acquisition Corp.

Share this article
Share this article
NEW YORK, May 4, 2021 /PRNewswire/ Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated
Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating
Blue Water Acquisition Corp. ( BLUW or the Company ) (BLUW) relating to its proposed merger with Clarus Therapeutics, Inc. Under the terms of the agreement, BLUW will acquire Clarus through a reverse merger, with Clarus emerging as a publicly traded company.
The investigation focuses on whether Blue Water Acquisition Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued. ....

New York , United States , Empire State Building , Prnewswire Juan Monteverde , Juane Monteverde , United States Supreme Court , Emulex Corp , Securities Class Action Services , Blue Water Acquisition Corp , Clarus Therapeutics Inc , Monteverde Associates , Class Action Services Report , New York City , Blue Water Acquisition , Clarus Therapeutics , Class Action Services , Securities Class , Super Lawyers , Rising Star , Securities Litigation , Exchange Act , United States Supreme , Monteverde Amp Associates Pc , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , பேரரசு நிலை கட்டிடம் ,

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Blue Water Acquisition Corp. ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Blue Water Acquisition Corp. .
Rigrodsky Law, P.AMay 5, 2021 GMT
WILMINGTON, Del., May 05, 2021 (GLOBE NEWSWIRE) Rigrodsky Law, P.A. announces that it is investigating Blue Water Acquisition Corp. (“Blue Water”) (NASDAQ GS: BLUW ) regarding possible breaches of fiduciary duties and other violations of law related to Blue Water’s agreement to merge with Clarus Therapeutics, Inc.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-blue-water-acquisition-corp.
ADVERTISEMENT
You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected]. ....

New York , United States , Ginam Serra , Sethd Rigrodsky , Blue Water Acquisition Corp , Clarus Therapeutics Inc , Blue Water Acquisition , Blue Water , Clarus Therapeutics , Toll Free , Globe Newswire , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , நீலம் தண்ணீர் கையகப்படுத்தல் கார்ப் , கிளாரஸ் சிகிச்சை இன்க் , நீலம் தண்ணீர் கையகப்படுத்தல் , நீலம் தண்ணீர் , கிளாரஸ் சிகிச்சை , சுங்கவரி இலவசம் ,